Has Justin Spooner received payments from drug or device companies?

Yes. Drug and device makers reported $11,845 in general payments to Justin Spooner across 530 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Justin Spooner did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Justin Spooner come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Justin Spooner

Child & Adolescent Psychiatry · Ponte Vedra Beach, FLNPI 1720269459

Payments from drug & device makers

$11,845in general payments, 2019–2025

Across 530 payments — averaging $22.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Eisai Inc.$2K
AbbVie$1K
Teva Pharmaceuticals USA, Inc.$845
Boston Scientific$762
Amgen$575
Otsuka America Pharmaceutical, Inc.$479
plus $6K from 50 others

What the payments were for

Speaking & faculty fees$1,92516%
Travel & lodging$1441%
Food & beverage$9,65682%
Education$1201%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Eisai Inc.	30	$2,459
AbbVie(2 entities)	73	$1,027
Teva Pharmaceuticals USA, Inc.	63	$845
Boston Scientific	21	$762
Amgen(2 entities)	29	$575
Otsuka America Pharmaceutical, Inc.	27	$479
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	29	$454
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	17	$442
Stimwave Technologies Incorporated	8	$356
Corium, LLC	15	$323
Biohaven Pharmaceuticals, Inc.	11	$275
Biohaven Pharmaceutical Holding Company Ltd.	10	$266
Lilly USA, LLC	11	$249
Novartis	14	$242
Axsome Therapeutics, Inc.	14	$214
Almatica Pharma LLC	12	$208
Takeda Pharmaceuticals U.S.A., Inc.	8	$198
Upsher-smith Laboratories LLC	9	$183
Tris Pharma Inc	10	$182
Supernus Pharmaceuticals, Inc.	9	$175
Lundbeck LLC	7	$161
Radius Health, Inc.	6	$143
Zyla Life Sciences, Inc.	22	$135
Flowonix Medical Incorporated	2	$132
Collegium Pharmaceutical, Inc.	7	$122
Neos Therapeutics, LP	7	$115
Vanda Pharmaceuticals Inc.	5	$114
Avanir Pharmaceuticals, Inc.	1	$113
Redhill Biopharma Inc.	6	$90
Neurocrine Biosciences, Inc.	4	$79
Merck	4	$64
E.r. Squibb & Sons, L.L.C.	3	$56
Arbor Pharmaceuticals, Inc.	3	$49
Vertical Pharmaceuticals, LLC	2	$44
Idorsia Pharmaceuticals US Inc	2	$42
IBSA Pharma Inc.	2	$40
Pfizer	3	$35
Johnson & Johnson(2 entities)	2	$34
Virtus Pharmaceuticals LLC	2	$33
Noven Therapeutics, LLC	2	$33
Pacira Therapeutics, Inc.	1	$30
Ironshore Pharmaceuticals Inc.	1	$28
Tersera Therapeutics LLC	2	$28
Nevro Corp.	1	$24
Nalu Medical, Inc.	1	$23
Scilex Pharmaceuticals Inc.	1	$21
Pear Therapeutics (US), Inc.	1	$21
Biodelivery Sciences International, Inc.	1	$18
Vertos Medical, Inc.	1	$17
Medtronic	1	$16
Kaleo, Inc.	1	$14
Aytu Biopharma, Inc.	2	$13
Captiva Spine Inc	1	$12
Bioventus LLC	1	$11
Curonix LLC	1	$11
Forte Bio-pharma LLC	1	$10

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,845 in reported general payments places this provider in the 90th percentile of 206 child & adolescent psychiatry providers in Florida.

See all child & adolescent psychiatry providers in Florida →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Aripiprazole	45	$2,632
Venlafaxine Hcl ErVenlafaxine Hcl	78	$1,090
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine	53	$1,060
Mirtazapine	32	$863
Clonazepam	65	$675
Fluoxetine Hcl	37	$519
Quetiapine Fumarate	22	$243
Lorazepam	18	$141
Gabapentin	13	$140
Bupropion XlBupropion Hcl	13	$109
Alprazolam	15	$90
Trazodone Hcl	15	$77
Zolpidem Tartrate	11	$38

Paid to pharmacies, not to this prescriber.

Other child & adolescent psychiatry in Ponte Vedra Beach

Jorge DiazPonte Vedra Beach$2K
Elias SarkisGainesville$4M
Ayesha LallGainesville$3.5M
Americo PadillaMiami$1.6M
Rosa Negron MunozLakeland$726K
Anand PatelGainesville$627K
Alexander PushkaHollywood$601K
Mark BarnettMiami Beach$290K
Craig KuninsGulfport$265K
Jose AlvarezMiami$229K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →